NasdaqGS - Delayed Quote USD
ZimVie Inc. (ZIMV)
At close: October 16 at 4:00 PM EDT
After hours: October 16 at 6:44 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
453,384.00
457,433.00
463,292.00
472,308.00
912,427.00
--
Cost of Revenue
167,254.00
167,050.00
169,346.00
175,971.00
312,908.00
--
Gross Profit
286,130.00
290,383.00
293,946.00
296,337.00
599,519.00
--
Operating Expense
292,898.00
301,638.00
311,287.00
263,157.00
668,278.00
--
Operating Income
-6,768.00
-11,255.00
-17,341.00
33,180.00
-68,759.00
--
Net Non Operating Interest Income Expense
-17,429.00
-20,234.00
-10,870.00
-405.00
-302.00
--
Other Income Expense
-19,841.00
-19,358.00
-26,289.00
-12,193.00
-152,287.00
--
Pretax Income
-44,039.00
-50,847.00
-54,500.00
20,582.00
-221,348.00
--
Tax Provision
10,821.00
5,202.00
-7,596.00
4,185.00
-42,349.00
--
Net Income Common Stockholders
-351,716.00
-393,282.00
-63,881.00
-95,254.00
-179,088.00
--
Diluted NI Available to Com Stockholders
-351,716.00
-393,282.00
-63,881.00
-95,254.00
-179,088.00
--
Basic EPS
-14.02
-14.87
-2.45
-3.65
-6.86
--
Diluted EPS
-14.02
-14.87
-2.45
-3.65
-6.86
--
Basic Average Shares
26,669.50
26,454.00
26,100.00
26,100.00
26,100.00
--
Diluted Average Shares
26,669.50
26,454.00
26,100.00
26,100.00
26,100.00
--
Total Operating Income as Reported
-29,838.00
-30,939.00
-46,487.00
21,818.00
-222,613.00
--
Total Expenses
460,152.00
468,688.00
480,633.00
439,128.00
981,186.00
--
Net Income from Continuing & Discontinued Operation
-351,716.00
-393,282.00
-63,881.00
-95,254.00
-179,088.00
--
Normalized Income
-36,635.49
-40,498.64
-21,809.29
25,452.51
-54,620.11
--
Interest Expense
18,541.00
20,234.00
10,870.00
405.00
302.00
--
Net Interest Income
-17,429.00
-20,234.00
-10,870.00
-405.00
-302.00
--
EBIT
-25,498.00
-30,613.00
-43,630.00
20,987.00
-221,046.00
--
EBITDA
48,517.00
91,073.00
79,159.00
150,706.00
-86,715.00
--
Reconciled Cost of Revenue
118,173.00
71,876.00
73,539.00
74,548.00
264,070.00
--
Reconciled Depreciation
74,015.00
121,686.00
122,789.00
129,719.00
134,331.00
--
Net Income from Continuing Operation Net Minority Interest
-54,860.00
-56,049.00
-46,904.00
16,397.00
-179,088.00
--
Total Unusual Items Excluding Goodwill
-23,069.00
-19,684.00
-29,146.00
-11,362.00
-153,854.00
--
Total Unusual Items
-23,069.00
-19,684.00
-29,146.00
-11,362.00
-153,854.00
--
Normalized EBITDA
71,586.00
110,757.00
108,305.00
162,068.00
67,139.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-4,844.49
-4,133.64
-4,051.29
-2,306.49
-29,386.11
--
12/31/2019 - 2/16/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ZBH Zimmer Biomet Holdings, Inc.
105.46
+0.82%
SRDX Surmodics, Inc.
38.53
-0.05%
AVNS Avanos Medical, Inc.
22.92
+0.53%
OFIX Orthofix Medical Inc.
16.02
+2.30%
LUNG Pulmonx Corporation
6.80
-2.30%
CVRX CVRx, Inc.
8.36
+4.24%
VREX Varex Imaging Corporation
12.00
+5.54%
INGN Inogen, Inc.
9.38
+1.41%
KIDS OrthoPediatrics Corp.
27.75
+2.66%
SIBN SI-BONE, Inc.
13.22
+0.61%